Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence

doi:10.3748/wjg.v21.i18.5607

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 18

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7825)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-8) series, Tables (1-4) series.

Item

Count

PDF

516

WORD

328

HTML

4340

Figures (1-8)

181

Tables (1-4)

139

Sum=5504

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1106

Download

1215

Sum=2321

May 14, 2015 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (20)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. May 14, 2015; 21(18): 5607-5621
Published online May 14, 2015. doi: 10.3748/wjg.v21.i18.5607

Table 3 Predictors of recurrence stratified according to recurrence time by Log-rank test

Variable	Recurrence, P value
Variable	Overall	Early	Late
Men	0.726	0.768	0.848
Age ≥ 62 yr	0.080	0.006	0.530
HBV	0.143	0.046	0.875
Cirrhosis	0.259	0.134	0.957
Ascites	0.022	0.219	0.028
ALT ≥ 44 U/L	0.086	0.118	0.429
AST ≥ 55 U/L	< 0.001	0.005	0.001
ALP ≥ 116 U/L	< 0.001	0.011	0.001
GGT ≥ 144 U/L	< 0.001	0.004	0.007
PLT ≥ 148 × 10⁹/L	0.021	0.376	0.009
PT (INR) ≥ 1.17	0.398	0.390	0.792
AFP ≥ 96 ng/mL	0.003	0.005	0.246
AFP ≥ 200 ng/mL	0.008	0.011	0.316
Tumor size ≥ 5 cm	< 0.001	< 0.001	0.001
Multiple tumors	0.125	0.169	0.471
Vascular invasion	0.063	0.205	0.150
CLIP ≥ 1	< 0.001	0.001	0.116
CLIP ≥ 2	< 0.001	< 0.001	0.386
Positive Pohl	0.748	0.683	0.993
Positive AARP	0.181	0.120	0.861
AAR ≥ 1.07	0.048	0.491	0.021
API ≥ 6	0.771	0.402	0.575
CDS ≥ 8	0.678	0.972	0.466
APRI ≥ 1.94	0.022	0.053	0.213
APRI ≥ 0.56	0.080	0.054	0.665
FIB-4 ≥ 4.3	0.044	0.130	0.152
FibroQ ≥ 6.36	0.025	0.131	0.084
Lok ≥ 0.33	0.836	0.698	0.870
Lok ≥ 0.70	0.078	0.592	0.026
GUCI ≥ 2.24	0.050	0.318	0.050
GUCI ≥ 0.65	0.125	0.088	0.757
APGA ≥ 26.9	< 0.001	< 0.001	0.333
PAPAS ≥ 2.41	< 0.001	0.002	0.034
PAPAS ≥ 3.62	< 0.001	0.001	0.024

AAR: Aspartate aminotransferase/alanine aminotransferase ratio; AARP: AAR-platelet count score; AFP: Alpha-fetoprotein; ALP: Alkaline phosphatase; ALT: Alanine aminotransferase; APGA: Aspartate aminotransferase/platelet count/γ-glutamyl transpeptidase/AFP index; API: Age/platelet count index; APRI: Aspartate aminotransferase/platelet count ratio index; AST: Aspartate aminotransferase; CDS: Cirrhosis discriminant score; CLIP: Cancer of the Liver Italian Program; FIB-4: Fibrosis index based on the four factors; FibroQ: Fibro-quotient; GGT: γ-glutamyl transpeptidase; GUCI: Goteburg University Cirrhosis Index; HBV: Hepatitis B virus; INR: International normalized ratio; PAPAS: Platelet count/age/ALP/AFP/AST index; PLT: Platelet count; PT: Prothrombin time.

Citation: Pang Q, Zhang JY, Xu XS, Song SD, Qu K, Chen W, Zhou YY, Miao RC, Liu SS, Dong YF, Liu C. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence. World J Gastroenterol 2015; 21(18): 5607-5621
URL: https://www.wjgnet.com/1007-9327/full/v21/i18/5607.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i18.5607